Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney H Falk

Showing results (91-100 of 158) with videos related to

Pageof 16
Sort By:
British Journal of Haematology|June 13, 2002
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosisVaishali Sanchorawala, Daniel G Wright, David C Seldin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 30, 2013
Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafishShikha Mishra, Jian Guan, Eva Plovie, et al.
Circulation. Heart Failure|April 16, 2015
Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomesMathew S Maurer, Donna R Grogan, Daniel P Judge, et al.
Circulation|February 25, 2014
Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosisCandida Cristina Quarta, Scott D Solomon, Imran Uraizee, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 5, 2022
Practical Points for Echocardiography in Cardiac AmyloidosisSarah A M Cuddy, Michael Chetrit, Madeline Jankowski, et al.
Circulation. Cardiovascular Imaging|August 12, 2015
18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography StudyMi-Ae Park, Robert F Padera, Anthony Belanger, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 24, 2019
Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using <sup>18</sup>F-Florbetapir PET/CTAriana Nodoushani, Mohammed Samir El-Sady, Mi-Ae Park, et al.
Blood|July 25, 2025
Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain AmyloidosisPedro Vianna, Rajshekhar Chakraborty, Shahrier Hossain, et al.
JACC. Heart Failure|July 15, 2019
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday PracticeRonald M Witteles, Sabahat Bokhari, Thibaud Damy, et al.
American Heart Journal|September 29, 2009
Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosisLawreen H Connors, Tatiana Prokaeva, Amareth Lim, et al.
Pageof 16

Showing results (91-100 of 158) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|June 13, 2002
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosisVaishali Sanchorawala, Daniel G Wright, David C Seldin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 30, 2013
Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafishShikha Mishra, Jian Guan, Eva Plovie, et al.
Circulation. Heart Failure|April 16, 2015
Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomesMathew S Maurer, Donna R Grogan, Daniel P Judge, et al.
Circulation|February 25, 2014
Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosisCandida Cristina Quarta, Scott D Solomon, Imran Uraizee, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 5, 2022
Practical Points for Echocardiography in Cardiac AmyloidosisSarah A M Cuddy, Michael Chetrit, Madeline Jankowski, et al.
Circulation. Cardiovascular Imaging|August 12, 2015
18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography StudyMi-Ae Park, Robert F Padera, Anthony Belanger, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 24, 2019
Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using <sup>18</sup>F-Florbetapir PET/CTAriana Nodoushani, Mohammed Samir El-Sady, Mi-Ae Park, et al.
Blood|July 25, 2025
Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain AmyloidosisPedro Vianna, Rajshekhar Chakraborty, Shahrier Hossain, et al.
JACC. Heart Failure|July 15, 2019
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday PracticeRonald M Witteles, Sabahat Bokhari, Thibaud Damy, et al.
American Heart Journal|September 29, 2009
Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosisLawreen H Connors, Tatiana Prokaeva, Amareth Lim, et al.
Pageof 16